China Pharma Holdings, Inc. (CPHI): Price and Financial Metrics

CPHI POWR Grades

• CPHI scores best on the Sentiment dimension, with a Sentiment rank ahead of 78.44% of US stocks.
• The strongest trend for CPHI is in Momentum, which has been heading up over the past 31 days.
• CPHI ranks lowest in Momentum; there it ranks in the 15th percentile.

CPHI Stock Summary

• CPHI has a market capitalization of $19,314,539 -- more than approximately merely 2.05% of US stocks.
• Price to trailing twelve month operating cash flow for CPHI is currently 68.22, higher than 94.13% of US stocks with positive operating cash flow.
• Revenue growth over the past 12 months for China Pharma Holdings Inc comes in at -11.84%, a number that bests merely 12.52% of the US stocks we're tracking.
• If you're looking for stocks that are quantitatively similar to China Pharma Holdings Inc, a group of peers worth examining would be MFGP, ITRN, FTEK, UG, and AIN.
• Visit CPHI's SEC page to see the company's official filings. To visit the company's web site, go to www.chinapharmaholdings.com.

CPHI Valuation Summary

• CPHI's EV/EBIT ratio is -10.3; this is 135.15% lower than that of the median Healthcare stock.
• CPHI's price/earnings ratio has moved down 10.5 over the prior 154 months.
• Over the past 154 months, CPHI's price/earnings ratio has gone down 10.5.

Below are key valuation metrics over time for CPHI.

CPHI Growth Metrics

The 5 year price growth rate now stands at 142%.
• Its 3 year net cashflow from operations growth rate is now at -82.31%.
• Its year over year price growth rate is now at 20.45%.

CPHI's revenue has moved down $2,647,026 over the prior 33 months.

The table below shows CPHI's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	9.683661	0.283142	-3.627794
2021-06-30	10.1057	0.5096	-3.811021
2021-03-31	11.46087	-0.075021	-2.973207
2020-12-31	10.86645	-0.04226	-2.866777
2020-09-30	10.98376	-1.172494	-20.403
2020-06-30	10.95993	-0.476228	-20.09405

CPHI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CPHI has a Quality Grade of C, ranking ahead of 56.06% of graded US stocks.
• CPHI's asset turnover comes in at 0.493 -- ranking 88th of 677 Pharmaceutical Products stocks.
• DRNA, ONVO, and CASI are the stocks whose asset turnover ratios are most correlated with CPHI.

The table below shows CPHI's key quality metrics over time.